About Apollo Neuroscience
Apollo Neuroscience is a Healthcare company based in Pittsburgh (United States) founded in 2017 by Kathryn Fantauzzi and David Rabin. Wearable technology is developed for stress reduction and sleep enhancement. It operates in the Healthcare and Technology sectors. Apollo Neuroscience has raised $30.66 million across 4 funding rounds from investors including Noetic Fund. Its chief executive, as recorded, is Kathryn Fantauzzi. Its website apolloneuro.com draws about 200 thousand monthly visits. Its focus areas include High Tech, Wearable Technology, Health and Wellness Devices and Mental Wellness. Its legal entity is APOLLO NEUROSCIENCE, INC. Its competitors include Freespira, Feel Therapeutics and Sensate; 3 of its 3 listed competitors have raised funding.
Company details
Apollo Neuroscience was founded in 2017 in Pittsburgh, United States, within the wearable technology sector. Devices are created to address stress reduction, sleep improvement, and performance enhancement through gentle vibrations that modulate the vagus nerve. Heart rate variability is influenced to support relaxation and rest. Patterns are tailored for stress management, focus, and sleep needs. Scientific research underpins the technology, which operates as a wellness aid.
- Total Equity Funding$30.66M (USD)
in 4 rounds
- Latest Funding Round$500K (USD), Series A
Apr 2024
- Investors
Apps and channels of Apollo Neuroscience
its YouTube channel Apollo Neuro has 4.3K subscribers and 30 videos.
Videos from Apollo Neuroscience
The most watched videos on Apollo Neuroscience's YouTube channel, Apollo Neuro (4.3K subscribers). Click a video to play it here.
More on Apollo Neuro.
Funding Insights of Apollo Neuroscience
Apollo Neuroscience has successfully raised a total of $30.66M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $500 thousand completed in April 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $30.66M
- Total Rounds 4
- Last Round Series A — $500,000
- First Round $5.89M
(Feb 2021)
- Investors Count 1
All 4 funding rounds of Apollo Neuroscience with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2024 | $500,000 | Series A | – | – | – |
| Feb 2023 | $9.27M | Series A | – | – | – |
| Mar 2022 | $15M | Series A | – | Noetic Psychedelic Fund | – |
| Feb 2021 | $5.89M | Series A | – | – | – |
1 investors in total: 1 institutional.
Investors in Apollo Neuroscience
Apollo Neuroscience has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Noetic Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Noetic Fund is engaged in global investments in emerging health technologies. | noeticfund.com | Toronto, Canada |
Investor details for Apollo Neuroscience
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Apollo Neuroscience
19 people are tracked at Apollo Neuroscience (6 in leadership, 8 in board & advisors, 5 in team).
| Name | Role | Group |
|---|---|---|
Kathryn Fantauzzi | Co-Founder & CEO | Leadership |
David Rabin | Co-Founder & CMO | Leadership |
Dave Rabin | Co-Founder & Co-Inventor, Chief Innovation Officer | Leadership |
Sam Roberts | Senior VP of Design | Leadership |
David Rabin MD, PhD | Co-founder & Chief Medical Officer | Leadership |
Matthew Runeare | VP Of Brand & Creative | Leadership |
Belinda Tan | Scientific Advisor | Board & advisors |
Ben Kelmendi | Scientific Advisor | Board & advisors |
Ronald D. Siegel | Scientific Advisor | Board & advisors |
Nicole Beurkens | Scientific Advisor | Board & advisors |
Joseph C. Maroon | Scientific Advisor | Board & advisors |
Bryan Donohue | Scientific Advisor | Board & advisors |
Rachel Yehuda | Scientific Advisor | Board & advisors |
Michael Breus | Scientific Advisor | Board & advisors |
Jesse T. Barbieri | Product Support Manager & Jr. Developer | Team |
Daniel Denunzio | Data Architect | Data Engineer | Analytics Engineer | Team |
James B. | Corporate Business Development | Team |
Frederick Connelly Thieman | General Counsel | Team |
Matthew Annis | Finance and Operations Manager | Team |
Complete people profiles for Apollo Neuroscience
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Apollo Neuroscience
3 dated milestones of Apollo Neuroscience across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Apollo Neuroscience is founded.
- Funding First funding round of $5.9M.
- Funding Latest funding round, Series A, of $500K.
Competitors of Apollo Neuroscience
Apollo Neuroscience has 3 listed competitors in our database, 3 of them funded. They include Freespira, Feel Therapeutics and Sensate.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| freespira.com | 2008 | Danville, United States | $48.94M | 25 | Panic disorders are treated via breathing device and mobile app. | |
| feeltherapeutics.com | 2015 | San Francisco, United States | $21.68M | Provider of digital Precision Medicine company leveraging objective data and passive measurement for mental healthcare | ||
| getsensate.com | 2019 | Los Angeles, United States | $6.05M | 5 | A relaxation device for stress and anxiety management is developed. |
Detailed competitors of Apollo Neuroscience
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Apollo Neuroscience
The website of Apollo Neuroscience (apolloneuro.com) receives about 199.5K visits a month and ranks #190,687 among all websites worldwide, #6,143 in Nutrition Diets and Fitness.
- Monthly visits199.5K
▼ 23.4% vs previous month
- Unique visitors129K
per month
- Global rank#190,687
among all websites
- Category rank#6,143
Health · Nutrition Diets and Fitness
- Bounce rate45%
- Pages per visit1.9
- Average visit1 min 46 sec
- DevicesDesktop 18% · Mobile 82%
Websites whose visitors overlap most with Apollo Neuroscience. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
resona.health | resona.health | 100% | #680,677 | – | |
eviering.com | eviering.com | 96% | #879,019 | – | |
| bioproteintech.com | 96% | 32.3K | #1,275,569 | View details | |
| troscriptions.com | 96% | View details | |||
| ouraring.com | 91% | 6.9M | #7,355 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Apollo Neuroscience
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Fitness & Wellness Platforms
3 companies that operate in the same segment as Apollo Neuroscience (Fitness & Wellness Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Smart fitness equipment and streaming platforms are provided. | 2011 | New York, New York, United States | USD 995.53 M | USD 2.45 B | 2,894 | |
Fitness class memberships are offered across various gyms and studios. | 2013 | New York, New York, United States | USD 550 M | 969 | ||
Subscription-based social networking platform for runners and cyclists | 2009 | San Francisco, California, United States | USD 180 M | 999 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Apollo Neuroscience
Complete news archive for Apollo Neuroscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Apollo Neuroscience
Apollo Neuroscience was founded in 2017 and raised its 1st funding round 4 years after it was founded.
Apollo Neuroscience is headquartered in Pittsburgh, United States. It is registered at Pittsburgh, Pennsylvania, United States.
Kathryn Fantauzzi is the CEO of Apollo Neuroscience, as recorded in our data. They have also founded this company.
Apollo Neuroscience is a funded company, having raised a total of $30.66M across 4 funding rounds to date. The company's 1st funding round was a Series A of $5.89M, raised on Feb 2021.
Apollo Neuroscience was founded in 2017 in Pittsburgh, United States, within the wearable technology sector. Devices are created to address stress reduction, sleep improvement, and performance enhancement through gentle vibrations that modulate the vagus nerve. Heart rate variability is influenced to support relaxation and rest. Patterns are tailored for stress management, focus, and sleep needs. Scientific research underpins the technology, which operates as a wellness aid.
Apollo Neuroscience's top competitors include Sensate, Freespira and Feel Therapeutics.
Apollo Neuroscience has 1 investor. Key investors include Noetic Fund.
Apollo Neuroscience operates through Apollo Neuroscience, Inc..
The website of Apollo Neuroscience receives about 200 thousand visits a month and ranks #190,687 among all websites worldwide.